From KenSci Gets $22M for Tools to Help Hospitals Flag High-Risk Patients:

KenSci co-founder and CEO Samir Manjure—

Seattle-based KenSci develops software designed to help healthcare organizations predict which of their patients are most likely to get sick. Image courtesy of KenSci.

Underwriters and Partners

Xconomy Insight

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

Sponsored · Webinar
Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

From KenSci Gets $22M for Tools to Help Hospitals Flag High-Risk Patients:

Underwriters and Partners

As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future

CMC in Drug Development and Life Cycle Management

Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines

Xconomy on Demand

We offer a number of ways to subscribe for free!